RadNet raises 2025 revenue guidance as advanced imaging volumes and digital health drive growth
View original at seekingalpha.comRadNet raises 2025 revenue guidance as advanced imaging volumes and digital health drive growth Earnings Call Insights: RadNet, Inc. (RDNT) Q3 2025 MANAGEMENT VIEW * CEO Howard Berger opened by stating, "I am very pleased with the performance in the third quarter…
What we drew from this source
The claims Via News extracted from this document. We point to the source; we don't replace it.
Labor markets for radiology technologists remain challenging but have stabilized, and RadNet is seeing increasing inbound calls from health systems for partnership opportunities.
80% confidenceCash balance as of September 30, 2025 was $804.7 million with net debt to adjusted EBITDA ratio of approximately 1.0.
80% confidenceVirtual radiology is an inevitability, and DeepHealth serves as a platform to bundle and integrate multiple AI modules for both internal and external customers.
80% confidenceiCAD contributed approximately $3.9 million in revenue during Q3 2025.
80% confidenceRadNet increased imaging center revenue guidance by $50 million at the low end and $30 million at the high end, and increased adjusted EBITDA guidance by $5 million at both ends.
80% confidenceEBCD AI revenue rose 28.7% year-over-year.
80% confidenceAI revenue within Digital Health, inclusive of iCAD revenue from ProFound AI and Deep Health solutions, increased 112% from Q3 2024.
80% confidenceDigital Health revenue increased 51.6% from Q3 2024, partially due to iCAD's revenue contribution since July 17 acquisition.
80% confidenceTechLive rollout should be substantially complete by the end of 2025, and has reduced exam closure hours by about 42% relative to last year.
80% confidencePET/CT growth is driven by PSMA and amyloid brain studies, which now make up 20% of PET/CT volume.
80% confidenceQ3 2025 revenue and adjusted EBITDA were both quarterly records and exceeded internal budgets set at the beginning of 2025.
80% confidenceTotal company revenue increased 13.4% and adjusted EBITDA increased 15.2% relative to Q3 2024, resulting in a 26 basis point improvement in adjusted EBITDA margins.
80% confidenceAdjusted EBITDA margins increased by 26 basis points from 16% to 16.2% year-over-year.
80% confidenceExposure to Medicaid and health insurance exchanges is minimal, reducing risk from policy changes.
80% confidenceRadNet operates 407 centers as of September 30, 2025, with one new center opened during Q3 and 4.9% total same-center procedure volume growth.
80% confidenceDSOs (Days Sales Outstanding) reduced to 31.9 days, the lowest historical level for RadNet.
80% confidenceAdvanced imaging volumes increased 13.0% on an aggregate basis and 9.9% on a same-center basis, driven by equipment upgrades, AI-driven scheduling, capacity expansion, and shift from hospital to ambulatory imaging.
80% confidence2026 Medicare reimbursement changes will benefit RadNet with approximately $4-5 million revenue uplift on roughly $2 billion of revenue.
80% confidenceEBCD payer adoption discussions are progressing positively with increasing traction, though large payers move slowly.
80% confidenceRadNet needs more sales personnel post-iCAD acquisition, and margin expansion will increasingly be driven by digital health tools.
80% confidenceAggregate MRI volume increased 14.8%, CT volume increased 9.4%, and PET/CT volume increased 21.1% from Q3 2024.
80% confidenceSee-Mode's thyroid ultrasound technology achieved a 30% reduction in scan time across 240+ centers.
80% confidence